Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Critical Care
Volume 2017, Article ID 1951965, 4 pages
https://doi.org/10.1155/2017/1951965
Case Report

Malignant Catatonia Warrants Early Psychiatric-Critical Care Collaborative Management: Two Cases and Literature Review

1Department of Medicine, Maricopa Medical Center, Phoenix, AZ, USA
2Department of Psychiatry, Maricopa Medical Center, Phoenix, AZ, USA
3College of Medicine, University of Arizona, Phoenix, AZ, USA
4College of Medicine, Mayo Clinic, Scottsdale, AZ, USA

Correspondence should be addressed to Julia Park; moc.liamg@krapailujot

Received 10 November 2016; Accepted 5 January 2017; Published 30 January 2017

Academic Editor: Gil Klinger

Copyright © 2017 Julia Park et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Oldham and H. B. Lee, “Catatonia vis-à-vis delirium: the significance of recognizing catatonia in altered mental status,” General Hospital Psychiatry, vol. 37, no. 6, pp. 554–559, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. P. M. Sadr, M. Hazeghazam, M. Bailon et al., “Management of a severe form of malignant catatonia: useful lessons in diagnosis and management,” in Proceedings of the American Psychiatric Association Annual Meeting, San Francisco, Calif, USA, March 2013.
  3. V. R. Velamoor, “Neuroleptic malignant syndrome,” Drug Safety, vol. 19, no. 1, pp. 73–82, 1998. View at Publisher · View at Google Scholar
  4. E. Castillo, R. T. Rubin, and E. Holsboer-Trachsler, “Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome,” The American Journal of Psychiatry, vol. 146, no. 3, pp. 324–328, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. A. F. Gross, F. A. Smith, and T. A. Stern, “Dread complications of catatonia: a case discussion and review of the literature,” Primary Care Companion to the Journal of Clinical Psychiatry, vol. 10, no. 2, pp. 153–155, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. G. L. Fricchione, A. F. Gross, J. C. Huffman, G. Bush, and T. A. Stern, “Catatonia, neuroleptic malignant syndrome, and serotonin syndrome,” in Massachusetts General Hospital Handbook of General Hospital Psychiatry, Elsevier, 2016, https://www.clinicalkey.com/#!/content/book/3-s2.0-B9781437719277000212. View at Google Scholar
  7. M. Fink, “Catatonia: a syndrome appears, disappears, and is rediscovered,” Canadian Journal of Psychiatry, vol. 54, no. 7, pp. 437–445, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. Woodbury and M. A. Woodbury, “Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 31, no. 6, pp. 1161–1164, 1992. View at Publisher · View at Google Scholar · View at Scopus
  9. W. W. Fleischhacker, B. Unterweger, J. M. Kane, and H. Hinterhuber, “The neuroleptic malignant syndrome and its differentiation from lethal catatonia,” Acta Psychiatrica Scandinavica, vol. 81, no. 1, pp. 3–5, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Francis, “Catatonia: diagnosis, classification, and treatment,” Current Psychiatry Reports, vol. 12, no. 3, pp. 180–185, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. F. U. Lang, S. Lang, T. Becker, and M. Jäger, “Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma,” Psychopharmacology, vol. 232, no. 1, pp. 1–5, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. B. T. Carroll, “The universal field hypothesis of catatonia and neuroleptic malignant syndrome,” CNS Spectrums, vol. 5, no. 7, pp. 26–33, 2000. View at Google Scholar · View at Scopus
  13. G. Northoff, “Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology,” Journal of Neural Transmission, vol. 109, no. 12, pp. 1453–1467, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Dąbrowski and T. Parnowski, “Clinical analysis of safety and effectiveness of electroconvulsive therapy,” Psychiatria Polska, vol. 46, no. 3, pp. 345–360, 2012. View at Google Scholar · View at Scopus
  15. O. Freudenreich, S. H. Nejad, A. Francis, and G. L. Fricchione, “Psychosis, mania, and catatonia,” in Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, J. L. Levenson, Ed., American Psychiatric, Washington, DC, USA, 2011. View at Google Scholar
  16. J. A. Van Waarde, J. H. A. M. Tuerlings, B. Verwey, and R. C. Van Der Mast, “Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients,” The Journal of ECT, vol. 26, no. 4, pp. 248–252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Luchini, P. Medda, M. Mariani, M. Mauri, C. Toni, and G. Perugi, “Electroconvulsive therapy in catatonic patients: efficacy and predictors of response,” World Journal of Psychiatry, vol. 5, no. 2, pp. 182–192, 2015. View at Google Scholar
  18. J. H. A. M. Tuerlings, J. A. van Waarde, and B. Verwey, “A retrospective study of 34 catatonic patients: analysis of clinical care and treatment,” General Hospital Psychiatry, vol. 32, no. 6, pp. 631–635, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. K. Boyarsky, M. Fuller, and T. Early, “Malignant catatonia-induced respiratory failure with response to ECT,” The Journal of ECT, vol. 15, no. 3, pp. 232–236, 1999. View at Google Scholar · View at Scopus
  20. J. C. Narayanaswamy, P. Tibrewal, A. Zutshi, R. Srinivasaraju, and S. B. Math, “Clinical predictors of response to treatment in catatonia,” General Hospital Psychiatry, vol. 34, no. 3, pp. 312–316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Haouzir, X. Lemoine, M. Petit et al., “The role of coagulation marker fibrin D-dimer in early diagnosis of catatonia,” Psychiatry Research, vol. 168, no. 1, pp. 78–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. W. Y. Lee, “Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome,” Journal of Clinical Psychopharmacology, vol. 30, no. 1, pp. 3–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. A. C. White, “Catatonia and the neuroleptic malignant syndrome—a single entity?” The British Journal of Psychiatry, vol. 161, pp. 558–560, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. V. R. Velamoor, “Neuroleptic malignant syndrome,” Drug Safety, vol. 19, no. 1, pp. 73–82, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Koch, S. Chandragiri, S. Rizvi, G. Petrides, and A. Francis, “Catatonic signs in neuroleptic malignant syndrome,” Comprehensive Psychiatry, vol. 41, no. 1, pp. 73–75, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Caroff, S. Mann, and P. Keck, “Specific treatment of the neuroleptic malignant syndrome,” Biological Psychiatry, vol. 44, no. 6, pp. 378–381, 1998. View at Publisher · View at Google Scholar
  27. S. C. Mann, S. N. Caroff, H. R. Bleier, R. E. Antelo, and H. Un, “Electroconvulsive therapy of the lethal catatonia syndrome,” Convulsive Therapy, vol. 6, no. 3, pp. 239–247, 1990. View at Google Scholar · View at Scopus
  28. J. M. Hawkins, K. J. Archer, S. M. Strakowski, and P. E. Keck Jr., “Somatic treatment of catatonia,” International Journal of Psychiatry in Medicine, vol. 25, no. 4, pp. 345–369, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Davis, P. G. Janicak, P. Sakkas, C. Gilmore, and Z. Wang, “Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome,” Convulsive Therapy, vol. 7, no. 2, pp. 111–120, 1991. View at Google Scholar · View at Scopus
  30. W. V. McCall, S. C. Mann, F. E. Shelp, and S. N. Caroff, “Fatal pulmonary embolism in the catatonic syndrome: two case reports and a literature review,” The Journal of Clinical Psychiatry, vol. 56, no. 1, pp. 21–25, 1995. View at Google Scholar · View at Scopus
  31. W. M. McDonald, T. W. Meeks, W. V. McCall, and C. F. Zorumski, “Electroconvulsive therapy,” in The American Psychiatric Publishing Textbook of Psychopharmacology, 2009, http://psychiatryonline.org/doi/full/10.1176/appi.books.9781585623860.as44. View at Google Scholar